Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up

Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up

Background Metabolic-associated fatty liver disease (MAFLD) is the most prevalent liver disease across the globe. One of the most effective treatments for this disease is weight loss. This study aimed to determine how metabolic and bariatric surgery (MBS) affects MAFLD sonographic grades. Methods In...

Full description

Saved in:
Bibliographic Details
Published in:Obesity surgery Vol. 34; no. 8; pp. 2974 - 2979
Main Authors: kahani, Mohadese, Delasaeimarvi, Saba, Zandbaf, Tooraj, Tabasiyan, Mohammad Reza, Meshkat, Mojtaba, Mirsadeghi, Ali, Ghamari, Mohammad Javad
Format: Journal Article
Language:English
Published: New York Springer US 01-08-2024
Springer Nature B.V
Subjects:
Adult
Bariatric Surgery
Body Mass Index
Female
Females
Follow-Up Studies
Gastrointestinal surgery
Humans
Liver diseases
Male
Medicine
Medicine & Public Health
Metabolism
Middle Aged
Non-alcoholic Fatty Liver Disease - diagnostic imaging
Non-alcoholic Fatty Liver Disease - surgery
Obesity, Morbid - complications
Obesity, Morbid - surgery
Original Contributions
Surgery
Treatment Outcome
Ultrasonography
Weight Loss
Metabolic-associated fatty liver disease
Metabolic and bariatric surgery
Gastric bypass
Ultrasonography
Sleeve gastrectomy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Metabolic-associated fatty liver disease (MAFLD) is the most prevalent liver disease across the globe. One of the most effective treatments for this disease is weight loss. This study aimed to determine how metabolic and bariatric surgery (MBS) affects MAFLD sonographic grades. Methods In 2021, a pre-post study was conducted on 73 patients who underwent MBS. The study collected demographic information and ultrasound grades of MAFLD before and after MBS. Results A total of 73 patients underwent MBS, with 58 females and 15 males. The patients had a mean age of 39.8 ± 8.88 years and a mean BMI of 42.12 ± 5.98 kg/m 2 . Of these patients, 53 (72.6%) underwent SG, while 20 (27.4%) underwent RYGB. The preoperative BMI for females and males decreased significantly at the 12-month follow-up ( P  = 0.0001). However, males experienced more prominent weight changes ( P  = 0.009), but there was no statistically significant difference in fatty liver grade changes after MBS between males and females ( P  = 0.056), which suggests that the effect of MBS on fatty liver grades is not gender-specific. There was a significant reduction in BMI and fatty liver grade for patients under and over 40 years old after surgery ( P  = 0.0001). However, there was no statistically significant difference in fatty liver grade and BMI changes after MBS between the two age groups. RYGB was found to be more effective than SG in reducing fatty liver grade, BMI, and %TWL ( P  < 0.05). Conclusion Bariatric surgery can play a vital role in reducing the weight and severity of metabolic-associated fatty liver disease. Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-8923
1708-0428
1708-0428
DOI:10.1007/s11695-024-07376-1